Suivre
Pierre sokoloff
Pierre sokoloff
Biodol Therapeutics
Adresse e-mail validée de biodol.eu - Page d'accueil
Titre
Citée par
Citée par
Année
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
P Sokoloff, B Giros, MP Martres, ML Bouthenet, JC Schwartz
Nature 347 (6289), 146-151, 1990
32981990
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA
ML Bouthenet, E Souil, MP Martres, P Sokoloff, B Giros, JC Schwartz
Brain research 564 (2), 203-219, 1991
11041991
Alternative splicing directs the expression of two D2 dopamine receptor isoforms
B Giros, P Sokoloff, MP Martres, JF Riou, LJ Emorine, JC Schwartz
Nature 342 (6252), 923-926, 1989
9091989
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H] hydroxy-N, N-di-n-propyl-2-aminotetralin.
D Levesque, J Diaz, C Pilon, MP Martres, B Giros, E Souil, D Schott, ...
Proceedings of the National Academy of Sciences 89 (17), 8155-8159, 1992
8471992
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
M Pilla, S Perachon, F Sautel, F Garrido, A Mann, CG Wermuth, ...
Nature 400 (6742), 371-375, 1999
7061999
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
O Guillin, J Diaz, P Carroll, N Griffon, JC Schwartz, P Sokoloff
Nature 411 (6833), 86-89, 2001
7022001
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor
P Sokoloff, M Andrieux, R Besançon, C Pilon, MP Martres, B Giros, ...
European Journal of Pharmacology: Molecular Pharmacology 225 (4), 331-337, 1992
4931992
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
E Bézard, S Ferry, U Mach, H Stark, L Leriche, T Boraud, C Gross, ...
Nature medicine 9 (6), 762-767, 2003
4552003
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
J Diaz, D Levesque, CH Lammers, N Griffon, MP Martres, JC Schwartz, ...
Neuroscience 65 (3), 731-745, 1995
4491995
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders
P Sokoloff, J Diaz, BL Foll, O Guillin, L Leriche, E Bezard, C Gross
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006
4222006
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa
R Bordet, S Ridray, S Carboni, J Diaz, P Sokoloff, JC Schwartz
Proceedings of the National Academy of Sciences 94 (7), 3363-3367, 1997
4141997
Novel dopamine receptors half a decade later
P Sokoloff, JC Schwartz
Trends in pharmacological sciences 16 (8), 270-275, 1995
4051995
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons
J Diaz, C Pilon, B Le Foll, C Gros, A Triller, JC Schwartz, P Sokoloff
Journal of Neuroscience 20 (23), 8677-8684, 2000
4022000
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.
MA Crocq, R Mant, P Asherson, J Williams, Y Hode, A Mayerova, ...
Journal of medical genetics 29 (12), 858-860, 1992
3821992
Widespread Distribution of Brain Dopamine Receptors Evidenced with [125I]Iodosulpride, a Highly Selective Ligand
MP Martres, ML Bouthenet, N Sales, P Sokoloff, JC Schwartz
Science 228 (4700), 752-755, 1985
3121985
D3 dopamine receptor mRNA is widely expressed in the human brain
M Suzuki, YL Hurd, P Sokoloff, JC Schwartz, G Sedvall
Brain research 779 (1-2), 58-74, 1998
3071998
Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders
L Lannfelt, P Sokoloff, MP Martres, C Pilon, B Giros, E Jönsson, G Sedvall, ...
Psychiatric Genetics 2 (4), 249-256, 1992
2891992
D2/D3 dopamine receptor heterodimers exhibit unique functional properties
M Scarselli, F Novi, E Schallmach, R Lin, A Baragli, A Colzi, N Griffon, ...
Journal of Biological Chemistry 276 (32), 30308-30314, 2001
2762001
Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions
JC Schwartz, J Diaz, C Pilon, P Sokoloff
Brain Research Reviews 31 (2-3), 277-287, 2000
2682000
A functional test identifies dopamine agonists selective for D3 versus D2 receptors
F Sautel, N Griffon, D Lévesque, C Pilon, JC Schwartz, P Sokoloff
Neuroreport 6 (2), 329-332, 1995
2641995
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20